{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:30:04Z","timestamp":1786116604265,"version":"build-2736575974"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007706","name":"Government of Italy Ministry of Economic Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007706","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.biopha.2026.119735","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T04:19:39Z","timestamp":1783397979000},"page":"119735","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Refining free fatty acid receptor agonism for metabolic control: Pharmacological and functional features of novel dual GPR40\/GPR120 ligands"],"prefix":"10.1016","volume":"201","author":[{"given":"Kashi","family":"Brunetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3173-4541","authenticated-orcid":false,"given":"Bruno","family":"Fassari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1210-6836","authenticated-orcid":false,"given":"Elisabetta","family":"Catalani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Galletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Del Quondam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Mocciaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9083-4935","authenticated-orcid":false,"given":"Matteo","family":"Giovarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"De Palma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana","family":"Perrotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7333-8270","authenticated-orcid":false,"given":"Emilio","family":"Clementi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Bianchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5959-4443","authenticated-orcid":false,"given":"Laura","family":"Brandolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8390-6614","authenticated-orcid":false,"given":"Andrea","family":"Aramini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2727-9449","authenticated-orcid":false,"given":"Davide","family":"Cervia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2026.119735_bib1","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/s41569-023-00877-z","article-title":"Cardiovascular risk in diabetes mellitus: epidemiology, assessment and prevention","volume":"20","author":"Wong","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.biopha.2026.119735_bib2","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.67428","article-title":"A Comprehensive Review of Metabolic Syndrome and Its Role in Cardiovascular Disease and Type 2 Diabetes Mellitus: Mechanisms, Risk Factors, and Management","author":"Dhondge","year":"2024","journal-title":"Cureus 16"},{"key":"10.1016\/j.biopha.2026.119735_bib3","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.tcm.2015.10.004","article-title":"Metabolic syndrome update","volume":"26","author":"Grundy","year":"2016","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.biopha.2026.119735_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.807548","article-title":"Trends in Antidiabetic Drug Discovery: FDA Approved Drugs, New Drugs in Clinical Trials and Global Sales","volume":"12","author":"Dahl\u00e9n","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119735_bib5","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s00125-025-06581-6","article-title":"Pharmacological therapies for type 2 diabetes: future approaches","volume":"69","author":"Bailey","year":"2025","journal-title":"Diabetologia"},{"key":"10.1016\/j.biopha.2026.119735_bib6","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/S0140-6736(06)69705-5","article-title":"The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes","volume":"368","author":"Drucker","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2026.119735_bib7","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/s41574-024-00979-9","article-title":"Targeting the incretin system in obesity and type 2 diabetes mellitus","volume":"20","author":"Ansari","year":"2024","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.biopha.2026.119735_bib8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cmet.2016.06.009","article-title":"The Cardiovascular Biology of Glucagon-like Peptide-1","volume":"24","author":"Drucker","year":"2016","journal-title":"Cell. Metab."},{"key":"10.1016\/j.biopha.2026.119735_bib9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12902-022-01036-0","article-title":"Glucagon-like peptide-1 (GLP-1) receptor agonists and cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of double-blind, randomized, placebo-controlled clinical trials","volume":"22","author":"Qin","year":"2022","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.biopha.2026.119735_bib10","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s13300-025-01829-1","article-title":"Rewriting Diabetes Therapy: How Incretin Modulation is Transforming Cardiovascular and Renal Outcomes","volume":"17","author":"Miramontes-Gonz\u00e1lez","year":"2026","journal-title":"Diabetes Ther."},{"key":"10.1016\/j.biopha.2026.119735_bib11","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0140-6736(25)02105-1","article-title":"Glucagon-like receptor agonists and next-generation incretin-based medications: metabolic, cardiovascular, and renal benefits","volume":"407","author":"Nauck","year":"2026","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2026.119735_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1170181","article-title":"Variation in responses to incretin therapy: Modifiable and non-modifiable factors","volume":"10","author":"Austin","year":"2023","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.biopha.2026.119735_bib13","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/00325481.2021.2002616","article-title":"Managing the gastrointestinal side effects of GLP-1 receptor agonists in obesity: recommendations for clinical practice","volume":"134","author":"Wharton","year":"2022","journal-title":"Postgrad. Med."},{"key":"10.1016\/j.biopha.2026.119735_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1043789","article-title":"Association between different GLP-1 receptor agonists and gastrointestinal adverse reactions: A real-world disproportionality study based on FDA adverse event reporting system database","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.biopha.2026.119735_bib15","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3390\/jcm12010145","article-title":"Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Glp-1 Receptor Agonists: A Multidisciplinary Expert Consensus","volume":"12","author":"Gorgojo-Mart\u00ednez","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.biopha.2026.119735_bib16","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1007\/s00125-023-05962-z","article-title":"Socioeconomic aspects of incretin-based therapy","volume":"66","author":"Karagiannis","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/j.biopha.2026.119735_bib17","doi-asserted-by":"crossref","first-page":"633","DOI":"10.7326\/M23-1492","article-title":"Cost-Effectiveness of Newer Pharmacologic Treatments in Adults With Type 2 Diabetes: A Systematic Review of Cost-Effectiveness Studies for the American College of Physicians","volume":"177","author":"Schousboe","year":"2024","journal-title":"Ann. Int. Med."},{"key":"10.1016\/j.biopha.2026.119735_bib18","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1152\/physrev.00041.2018","article-title":"Free Fatty Acid Receptors in Health and Disease","volume":"100","author":"Kimura","year":"2020","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.biopha.2026.119735_bib19","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41574-020-00459-w","article-title":"Targeting lipid GPCRs to treat type 2 diabetes mellitus - progress and challenges","volume":"17","author":"Ghislain","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.biopha.2026.119735_bib20","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/s41401-023-01215-2","article-title":"GPCRs involved in metabolic diseases: pharmacotherapeutic development updates","volume":"45","author":"Jin","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.biopha.2026.119735_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1043828","article-title":"Learn from failures and stay hopeful to GPR40, a GPCR target with robust efficacy, for therapy of metabolic disorders","volume":"13","author":"Guan","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119735_bib22","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.3390\/ijms26062501","article-title":"Potential Therapeutic Exploitation of G Protein-Coupled Receptor 120 (GPR120\/FFAR4) Signaling in Obesity-Related Metabolic Disorders","volume":"26","author":"Szukiewicz","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119735_bib23","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.2337\/db08-0307","article-title":"Gpr40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of incretin secretion","volume":"57","author":"Edfalk","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2026.119735_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.956277","article-title":"Free fatty acid receptors in the endocrine regulation of glucose metabolism: Insight from gastrointestinal-pancreatic-adipose interactions","volume":"13","author":"Zhao","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.biopha.2026.119735_bib25","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nature01478","article-title":"Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40","volume":"422","author":"Itoh","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119735_bib26","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nm1168","article-title":"Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120","volume":"11","author":"Hirasawa","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2026.119735_bib27","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.cell.2010.07.041","article-title":"GPR120 Is an Omega-3 Fatty Acid Receptor Mediating Potent Anti-inflammatory and Insulin-Sensitizing Effects","volume":"142","author":"Oh","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2026.119735_bib28","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1021\/acs.chemrev.6b00056","article-title":"Complex Pharmacology of Free Fatty Acid Receptors","volume":"117","author":"Milligan","year":"2017","journal-title":"Chem. Rev."},{"key":"10.1016\/j.biopha.2026.119735_bib29","doi-asserted-by":"crossref","first-page":"7061","DOI":"10.1021\/jm8010178","article-title":"Discovery of potent and selective agonists for the free fatty acid receptor 1 (FFA(1)\/GPR40), a potential target for the treatment of type II diabetes","volume":"51","author":"Christiansen","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2026.119735_bib30","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1194\/jlr.M075044","article-title":"GPR120 suppresses adipose tissue lipolysis and synergizes with GPR40 in antidiabetic efficacy","volume":"58","author":"Satapati","year":"2017","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.biopha.2026.119735_bib31","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1017\/S000711451500118X","article-title":"Activity of dietary fatty acids on FFA1 and FFA4 and characterisation of pinolenic acid as a dual FFA1\/FFA4 agonist with potential effect against metabolic diseases","volume":"113","author":"Christiansen","year":"2015","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.biopha.2026.119735_bib32","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1021\/acsmedchemlett.2c00160","article-title":"Optimization of First-in-Class Dual-Acting FFAR1\/FFAR4 Allosteric Modulators with Novel Mode of Action","volume":"13","author":"L\u00fcckmann","year":"2022","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2026.119735_bib33","doi-asserted-by":"crossref","first-page":"4774","DOI":"10.3390\/nu15224774","article-title":"Identification of Crocetin as a Dual Agonist of GPR40 and GPR120 Responsible for the Antidiabetic Effect of Saffron","volume":"15","author":"Zhao","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2026.119735_bib34","doi-asserted-by":"crossref","first-page":"9622","DOI":"10.3390\/ijms25179622","article-title":"GPR40\/GPR120 Agonist GW9508 Improves Metabolic Syndrome-Exacerbated Periodontitis in Mice","volume":"25","author":"Li","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119735_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111613","article-title":"A new synthetic dual agonist of GPR120\/GPR40 induces GLP-1 secretion and improves glucose homeostasis in mice","volume":"139","author":"Bianchini","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2026.119735_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107769","article-title":"A novel free fatty acid receptor agonist improving metabolic health in Drosophila models","volume":"216","author":"Brunetti","year":"2025","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biopha.2026.119735_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105488","article-title":"Retinal damage in a new model of hyperglycemia induced by high-sucrose diets","volume":"166","author":"Catalani","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biopha.2026.119735_bib38","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.3390\/antiox10081197","article-title":"Nutraceutical Strategy to Counteract Eye Neurodegeneration and Oxidative Stress in Drosophila melanogaster Fed with High-Sugar Diet","volume":"10","author":"Catalani","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.biopha.2026.119735_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115298","article-title":"Neuroprotective role of plumbagin on eye damage induced by high-sucrose diet in adult fruit fly Drosophila melanogaster","volume":"166","author":"Catalani","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2026.119735_bib40","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3390\/antiox14010116","article-title":"The Role of Extracts of Edible Parts and Production Wastes of Globe Artichoke (Cynara cardunculus L. var. scolymus (L.)) in Counteracting Oxidative Stress","volume":"14","author":"Laghezza Masci","year":"2025","journal-title":"Antioxidants"},{"key":"10.1016\/j.biopha.2026.119735_bib41","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1007\/s00018-020-03598-5","article-title":"Defects of full-length dystrophin trigger retinal neuron damage and synapse alterations by disrupting functional autophagy","volume":"78","author":"Catalani","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.biopha.2026.119735_bib42","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.1021\/acs.jmedchem.0c01002","article-title":"GPR120\/FFAR4 Pharmacology: Focus on Agonists in Type 2 Diabetes Mellitus Drug Discovery","volume":"64","author":"Carullo","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2026.119735_bib43","doi-asserted-by":"crossref","first-page":"21131","DOI":"10.1074\/jbc.M115.644450","article-title":"\u03b2-arrestin recruitment and biased agonism at free fatty acid receptor 1","volume":"290","author":"Mancini","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2026.119735_bib44","doi-asserted-by":"crossref","first-page":"10891","DOI":"10.1021\/acs.jmedchem.6b00892","article-title":"The Discovery, Preclinical, and Early Clinical Development of Potent and Selective GPR40 Agonists for the Treatment of Type 2 Diabetes Mellitus (LY2881835, LY2922083, and LY2922470)","volume":"59","author":"Hamdouchi","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2026.119735_bib45","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.cmet.2021.05.018","article-title":"Discovering signaling mechanisms governing metabolism and metabolic diseases with Drosophila","volume":"33","author":"Kim","year":"2021","journal-title":"Cell. Metab."},{"key":"10.1016\/j.biopha.2026.119735_bib46","doi-asserted-by":"crossref","first-page":"523","DOI":"10.18632\/aging.100185","article-title":"Adult Drosophila melanogaster as a model for the study of glucose homeostasis","volume":"2","author":"Haselton","year":"2010","journal-title":"Aging"},{"key":"10.1016\/j.biopha.2026.119735_bib47","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ydbio.2021.01.019","article-title":"Balancing energy expenditure and storage with growth and biosynthesis during Drosophila development","volume":"475","author":"Gillette","year":"2021","journal-title":"Dev. Biol."},{"key":"10.1016\/j.biopha.2026.119735_bib48","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.3389\/fphar.2019.01482","article-title":"Drug-Induced Liver Injury: Biomarkers, Requirements, Candidates, and Validation","volume":"10","author":"Meunier","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119735_bib49","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1146\/annurev-physiol-021115-105439","article-title":"Enteroendocrine Cells: Chemosensors in the Intestinal Epithelium","volume":"78","author":"Gribble","year":"2016","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.biopha.2026.119735_bib50","doi-asserted-by":"crossref","first-page":"11303","DOI":"10.1074\/jbc.M211495200","article-title":"The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids","volume":"278","author":"Briscoe","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2026.119735_bib51","first-page":"110","article-title":"Free-fatty acid receptor-4 (GPR120): Cellular and molecular function and its role in metabolic disorders","author":"Moniri","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119735_bib52","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1111\/bph.12879","article-title":"Characterizing pharmacological ligands to study the long-chain fatty acid receptors GPR40\/FFA1 and GPR120\/FFA4","volume":"172","author":"Milligan","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119735_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2024.108784","article-title":"Biased agonism at free-fatty acid receptor-4 (FFA4\/GPR120)","volume":"266","author":"Teyani","year":"2025","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2026.119735_bib54","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3390\/biom12020221","article-title":"Phenotyping of Drosophila melanogaster-A Nutritional Perspective","volume":"12","author":"Eickelberg","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.biopha.2026.119735_bib55","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature10798","article-title":"Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human","volume":"483","author":"Ichimura","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119735_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114942","article-title":"The Beneficial Effects of n-3 Polyunsaturated Fatty Acids on Diet Induced Obesity and Impaired Glucose Control Do Not Require Gpr120","volume":"9","author":"Bjursell","year":"2014","journal-title":"PLoS. One"},{"key":"10.1016\/j.biopha.2026.119735_bib57","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1242\/dmm.007948","article-title":"A high-sugar diet produces obesity and insulin resistance in wild-type Drosophila","volume":"4","author":"Musselman","year":"2011","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.biopha.2026.119735_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003175","article-title":"A Drosophila model of high sugar diet-induced cardiomyopathy","volume":"9","author":"Na","year":"2013","journal-title":"PLoS. Genet."},{"key":"10.1016\/j.biopha.2026.119735_bib59","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.cmet.2010.09.014","article-title":"High-fat-diet-induced obesity and heart dysfunction are regulated by the TOR pathway in Drosophila","volume":"12","author":"Birse","year":"2010","journal-title":"Cell. Metab."},{"key":"10.1016\/j.biopha.2026.119735_bib60","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1242\/dmm.012989","article-title":"Modeling metabolic homeostasis and nutrient sensing in Drosophila: implications for aging and metabolic diseases","volume":"7","author":"Owusu-Ansah","year":"2014","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.biopha.2026.119735_bib61","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2009.08.001","article-title":"TGR5-Mediated Bile Acid Sensing Controls Glucose Homeostasis","volume":"10","author":"Thomas","year":"2009","journal-title":"Cell. Metab."},{"key":"10.1016\/j.biopha.2026.119735_bib62","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.plipres.2009.11.001","article-title":"Bile acid-activated receptors in the treatment of dyslipidemia and related disorders","volume":"49","author":"Fiorucci","year":"2010","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.biopha.2026.119735_bib63","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1007\/s00125-023-05929-0","article-title":"Gut hormone-based pharmacology: novel formulations and future possibilities for metabolic disease therapy","volume":"66","author":"Tsch\u00f6p","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/j.biopha.2026.119735_bib64","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/nrendo.2017.161","article-title":"Animal models of obesity and diabetes mellitus","volume":"14","author":"Kleinert","year":"2018","journal-title":"Nat. Rev. Endocrinol."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226007717?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226007717?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T11:39:03Z","timestamp":1786016343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226007717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":64,"alternative-id":["S0753332226007717"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119735","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Refining free fatty acid receptor agonism for metabolic control: Pharmacological and functional features of novel dual GPR40\/GPR120 ligands","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119735","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119735"}}